Refining the American guidelines for prevention of cardiovascular disease

Lancet. 2014 Feb 15;383(9917):598. doi: 10.1016/S0140-6736(14)60212-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Practice Guidelines as Topic*
  • Primary Prevention*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors